United Therapeutics Financial Ratios
NASDAQ: UTHRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
United Therapeutics ratio analysis
United Therapeutics earned a net margin of 41.9% in FY 2025, up from 41.5% a year earlier. Gross margin was 87.9% compared with a median of 92.2% over the prior 9 years. Return on equity reached 18.8%, meaning United Therapeutics generated 0.19 dollars of profit for every dollar of shareholders' equity.
At the end of FY 2025, UTHR traded at 17.8 times earnings; across the 9 fiscal years shown, its year-end P/E ranged from 8.4 to 21.5, with a median of 14.5. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
United Therapeutics financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 17.83 | 14.46 | 11.10 | 18.54 | 21.48 | 13.15 | — | 8.39 | 15.89 | 9.41 |
| Price / sales | 6.91 | 5.60 | 4.42 | 6.53 | 5.76 | 4.52 | 2.61 | 3.00 | 3.77 | 3.93 |
| Price / book | 3.10 | 2.50 | 1.72 | 2.64 | 2.45 | 1.98 | 1.36 | 1.75 | 3.10 | 3.39 |
| Gross margin | 87.9% | 89.2% | 88.9% | 92.2% | 92.7% | 92.7% | 91.9% | 87.8% | 93.9% | 95.5% |
| Operating margin | 46.9% | 47.9% | 50.9% | 50.6% | 33.0% | 40.0% | -12.9% | 49.5% | 47.2% | 66.4% |
| Net margin | 41.9% | 41.5% | 42.3% | 37.6% | 28.2% | 34.7% | -7.2% | 36.2% | 24.2% | 44.6% |
| Free cash flow margin | 32.7% | 37.6% | 32.1% | 34.3% | 28.3% | 46.9% | -20.0% | 36.5% | 22.5% | 37.9% |
| Return on equity (ROE) | 18.8% | 18.5% | 16.5% | 15.2% | 12.0% | 15.2% | -3.8% | 21.1% | 19.9% | 38.6% |
| Return on assets (ROA) | 16.9% | 16.2% | 13.7% | 12.0% | 9.2% | 11.2% | -2.7% | 17.3% | 14.5% | 30.7% |
| Current ratio | 6.60 | 5.25 | 4.41 | 9.85 | 7.61 | 6.70 | 4.03 | 6.39 | 3.26 | 4.29 |
| Revenue growth | 10.6% | 23.6% | 20.2% | 14.9% | 13.6% | 2.4% | -11.0% | -5.7% | 7.9% | 9.1% |
| EPS growth | 13.1% | 24.4% | 32.1% | 49.1% | -12.8% | — | -117.8% | 43.8% | -39.0% | 19.9% |